International Flavors & Fragrances ROE 2010-2023 | IFF
Current and historical return on equity (ROE) values for International Flavors & Fragrances (IFF) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| International Flavors & Fragrances ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2023-12-31 |
$-2.57B |
$14.64B |
-15.30% |
| 2023-09-30 |
$0.02B |
$17.01B |
0.10% |
| 2023-06-30 |
$-2.20B |
$17.66B |
-12.59% |
| 2023-03-31 |
$-2.12B |
$17.79B |
-11.69% |
| 2022-12-31 |
$-1.87B |
$17.69B |
-9.87% |
| 2022-09-30 |
$-1.76B |
$16.92B |
-8.86% |
| 2022-06-30 |
$0.64B |
$20.29B |
3.03% |
| 2022-03-31 |
$0.56B |
$20.97B |
2.61% |
| 2021-12-31 |
$0.27B |
$21.12B |
1.25% |
| 2021-09-30 |
$0.25B |
$21.47B |
1.39% |
| 2021-06-30 |
$0.14B |
$21.80B |
0.99% |
| 2021-03-31 |
$0.20B |
$21.68B |
1.97% |
| 2020-12-31 |
$0.36B |
$6.32B |
5.99% |
| 2020-09-30 |
$0.38B |
$6.09B |
6.29% |
| 2020-06-30 |
$0.42B |
$6.00B |
6.99% |
| 2020-03-31 |
$0.47B |
$5.84B |
7.74% |
| 2019-12-31 |
$0.46B |
$6.23B |
7.40% |
| 2019-09-30 |
$0.39B |
$6.07B |
6.29% |
| 2019-06-30 |
$0.35B |
$6.21B |
6.31% |
| 2019-03-31 |
$0.32B |
$6.15B |
7.05% |
| 2018-12-31 |
$0.34B |
$6.04B |
9.90% |
| 2018-09-30 |
$0.28B |
$4.04B |
12.27% |
| 2018-06-30 |
$0.30B |
$1.76B |
17.06% |
| 2018-03-31 |
$0.31B |
$1.78B |
17.89% |
| 2017-12-31 |
$0.30B |
$1.69B |
17.51% |
| 2017-09-30 |
$0.42B |
$1.76B |
24.82% |
| 2017-06-30 |
$0.40B |
$1.68B |
23.85% |
| 2017-03-31 |
$0.40B |
$1.63B |
24.28% |
| 2016-12-31 |
$0.41B |
$1.63B |
24.45% |
| 2016-09-30 |
$0.41B |
$1.70B |
24.52% |
| 2016-06-30 |
$0.42B |
$1.68B |
25.89% |
| 2016-03-31 |
$0.41B |
$1.64B |
25.35% |
| 2015-12-31 |
$0.42B |
$1.60B |
26.17% |
| 2015-09-30 |
$0.43B |
$1.60B |
27.16% |
| 2015-06-30 |
$0.43B |
$1.63B |
27.02% |
| 2015-03-31 |
$0.44B |
$1.57B |
27.44% |
| 2014-12-31 |
$0.41B |
$1.52B |
26.33% |
| 2014-09-30 |
$0.39B |
$1.64B |
24.70% |
| 2014-06-30 |
$0.38B |
$1.60B |
25.01% |
| 2014-03-31 |
$0.37B |
$1.52B |
25.44% |
| 2013-12-31 |
$0.35B |
$1.47B |
25.25% |
| 2013-09-30 |
$0.36B |
$1.44B |
26.78% |
| 2013-06-30 |
$0.28B |
$1.37B |
21.35% |
| 2013-03-31 |
$0.26B |
$1.31B |
20.94% |
| 2012-12-31 |
$0.25B |
$1.25B |
20.60% |
| 2012-09-30 |
$0.21B |
$1.25B |
17.55% |
| 2012-06-30 |
$0.28B |
$1.23B |
23.33% |
| 2012-03-31 |
$0.26B |
$1.20B |
22.41% |
| 2011-12-31 |
$0.27B |
$1.11B |
23.15% |
| 2011-09-30 |
$0.30B |
$1.20B |
26.53% |
| 2011-06-30 |
$0.29B |
$1.19B |
27.60% |
| 2011-03-31 |
$0.28B |
$1.10B |
29.09% |
| 2010-12-31 |
$0.26B |
$1.00B |
29.18% |
| 2010-09-30 |
$0.26B |
$0.95B |
30.11% |
| 2010-06-30 |
$0.23B |
$0.85B |
28.88% |
| 2010-03-31 |
$0.21B |
$0.82B |
27.61% |
| 2009-12-31 |
$0.20B |
$0.77B |
26.90% |
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Consumer Products - Misc. Discretionary |
$21.347B |
$11.479B |
|
Flavors & Fragrances is a global leader in high-value ingredients and solutions for food and beverage, home and personal care, and health & wellness markets. It has 4 business units: Nourish, Scent, Health & Biosciences and Pharma Solutions; comprising 3 platforms: Ingredients, Flavors & Food Designs. Ingredients provide texturizing solutions to the food industry, food protection solutions for food and beverage products, specialty soy & pea protein with value-added formulations, emulsifiers and sweeteners. Flavors provide a range of flavor compounds & natural taste solutions, and value-added spices and seasoning ingredients. Food Designs offer savory solution products. Health & Biosciences includes, Health, Cultures & Food Enzymes, Home & Personal Care, Animal Nutrition, Grain Processing and Microbial Control, with a biotechnology-driven portfolio of products that serve the health and wellness, food, consumer and industrial markets. Pharma Solutions produces cellulosics and alginates-based pharma excipients.
|
